Abstract
Senile plaques (SP) are one of the characteristic pathological lesions of Alzheimer's disease (AD). They are also seen in the brains of some non-demented individuals as an age-related change. Identification of clinical conditions associated with these “incidental” SP could provide insight into AD pathogenesis. We have examined the presence of SP in lobectomy specimens (n=101) removed in the surgical treatment of temporal lobe epilepsy (TLE). SP were present in 10 specimens from epileptic patients aged 36 to 61 years and the presence of SP correlated positively with patient age. No other significant AD-related pathology was identified and no patients showed any evidence of dementia on neuropsychological testing. When compared with temporal lobe tissue from non-demented, non-epileptic autopsy controls (n=406), the density and distribution of SP was the same. The age-related incidence of SP however, was significantly greater in the epileptics. This suggests that some aspects of TLE has a positive influence on the formation of SP.
Similar content being viewed by others
References
Abe K, St. George-Hyslop PH, Tanzi RE, Kogure K (1991) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 125: 169–171
Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125: 172–174
Arriagada PV, Marzloff BA, Bradley TH (1992) Distribution of Alzheimer-type pathologic changes in non-demented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681–1688
Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375–403
Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC (1990) A case-control study of Alzheimer's disease in Australia. Neurology 40: 1698–1770
Burke WJ, O'Malley KL, Chung HD, Harmon SK, Miller JP, Berg L (1991) Effect of pre-and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res 11: 37–41
Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514–516
Card JP, Meade RP, Davis LG (1988) Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1: 835–846
Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634
Corsellis JAN (1970) The neuropathology of temporal lobe epilepsy. In: Williams D (ed.) Modern trends in neurology. Butterworths, London, pp 254–270
Corsellis JAN, Bruton CJ (1983) Neuropathology of status epilepticus in humans. Adv Neurol 34: 129–139
Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunohistochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688–1693
Delaere P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw JJ (1990) Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 116: 87–93
Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward P (1990) Cleavage of amyloid β peptide during constitutive processing of its precurson. Science 248: 1122–1124
Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg BD, Younkin SG (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255: 726–728
Glenner GG, Wong CW (1984) Alzheimer disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890
Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rosser M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704–706
Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J 6: 3627–3632
Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4: 253–267
Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877–880
Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging; 10: 593–602
Hofman A, Schulte W, Tanja TA, Van Duijn CM, Haaxma R, Lameris AJ, Otten VM, Saan RJ (1989) History of dementia and Parkinson's disease in first degree relatives of patients with Alzheimer's disease. Neurology 39: 1589–1592
Joachim CL, Selkoe DJ (1992) The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord 6: 7–34
Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 733–736
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 311: 530–532
Koh J-Y, Yang LL, Cotman CW (1990) β-Amyloid protein increases the vulnerability of of cultured cortical neurons to excitotoxic damage. Brain Res 533: 315–320
Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ (1991) Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 41: 1393–1397
Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 88: 7274–7251
Mann DMA (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43: 99–136
Mann DMA, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89: 169–179
Mann DMA, Tucker CM, Yates PO (1987) The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathol Appl Neurobiol 13: 123–139
Mann DM, Jones D, South PW, Snowden JS, Neary D (1992) Deposition of amyloid β protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease. Acta Neuropathol 83: 415–419
Margerison JH, Corsellis JAN (1966) Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89: 499–530
Mastaglia F, Masters CL, Beyreuther K, Kakulas BA (1988) Deposition of amyloid (A4) protein in the cerebral cortex in Parkinson's disease. Alzheimer Dis Assoc Disord 2: 254
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249
Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376–389
Meldrum BS, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379–387
Mita S, Schon EA, Herbert J (1989) Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Pathol 134: 1253–1261
Motte J, Williams RS (1989) Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 77: 535–546
Munoz DG, McLachlan RS, Blume WT, Kaufmann J, Girvin JP (1990) Abundant neuritic plaques in the temporal lobes of 2 non-demented patients treated surgically for temporal lobe epilepsy (abstract) Neurology 40: 338
Naruse S, Igarashi S, Kobagashi H, Aoki K, Inuzuka T, Kaneko K, Shimizu T, Iihara K, Kojima T, Miyatake T (1991) Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337: 978–979
Norstedt C, Gandy SE, Alafuzoff I, Caoraso GL, Iverfeldt K, Grebb JA, Winblad B, Greengard P (1991) Alzheimer βA4-amyloid precursor protein in human brain: aging-associated increased in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA 88: 8910–8914
Oliver C, Holland AJ (1986) Down's syndrome and Alzheimer's disease — A review. Psychol Med 16: 307–322
Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12: 295–312
Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84: 4190–4194
Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320: 1446–1451
Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487–498
Shalat SL, Seltzer B, Pidcock C, Baker EL (1987) Risk factors for Alzheimer's disease: a case-control study. Neurology 37: 1630–1633
Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests role in cell contact. EMBO J 7: 1365–1370
Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492–495
Spargo E, Luthert PJ, Jonata I, Lantos PL (1992) βA4 deposition in the temporal cortex of adult with Down's syndrome. J Neurol Sci 111: 26–32
Sparks DL, Hunsaker JL, Scheff SW, Kryscio RJ, Henson JL, Markesbury WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11: 601–607
Tamaoka A, Kalaria R, Lieberburg I, Selkoe D (1992) Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc Natl Acad Sci USA 89: 1345–1349
Tan N, Mastaglia F, Masters CL, Beyreuther K, Kakulas BA (1988) Amyloid (A4) deposition in brain in progressive supranuclear palsy (PSP). Alzheimer Dis Assoc Disord 2: 264
Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St. George-Hyslop P, van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer's locus. Science 235: 880–884
Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7: 331–356
Ulrich J (1985) Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 17: 273–277
Van Duijn CM, Hendricks L, Cruts M, Hardy JA, Hofman A, Van Broeckhoven C (1991) Amyloid precursor protein gene mutation in early onset Alzheimer's disease. Lancet 337: 978
Van Duijn CM, Hofman A (1991) Risk factors for Alzheimer's disease: a collaborative re-analysis of case control studies. Int J Epidemiol 20 [Suppl 2]: S1-S73
Wakita H, Tomimoto H, Akiguchi I, Ohnishi K, Nakamura S, Kimura J (1992) Regional accumulation of amyloid β/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci Lett 146: 135–138
Whalley LJ (1982) The dementia of Down's syndrome and its relevance to aetological studies of Alzheimer's disease. Ann NY Acad Sci 396: 39–53
Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y (1988) Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol 77: 113–119
Yamaguchi H, Haga C, Hirai S, Nakazato Y, Kosaka K (1990) Distinctive, rapid and easy labelling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol 79: 569–572
Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250: 279–282
Zimmerman K, Herget T, Salbaum JM, Schubert W, Hilbich C, Cramer M, Masters CL, Multhaup G, Kang J, Lemaire HG, Beyreuther R, Starzinski-Powitz A (1988) Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J 7: 367–372
Author information
Authors and Affiliations
Additional information
Generously supported by a grant from the Alzheimer Association of Ontario
Rights and permissions
About this article
Cite this article
Mackenzie, I.R.A., Miller, L.A. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 87, 504–510 (1994). https://doi.org/10.1007/BF00294177
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00294177